Abstract
Atezolizumab (Tecentriq, MPDL3280A; Genentech/Roche) is an Fc gamma R binding-deficient, fully humanized IgG1 mAb designed to interfere with the bindi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
